Organization
Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University
1 abstract
Abstract
Phase II study of pembrolizumab and lenvatinib in platinum sensitive recurrent ovarian cancer.Org: Department of Physiology and Pharmacology, Faculty of Medicine, Tel-Aviv University, Department of Physiology and Pharmacology, Faculty of Medicine, Tel Aviv University,